Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from Africa

This publication has 49 references indexed in Scilit:

• Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein
  Infection and Immunity, 2008
• Prevalence of Factor H–Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B Vaccine
  The Journal of Infectious Diseases, 2007
• Proteomic Analysis of Outer Membranes and Vesicles from Wild-Type Serogroup B Neisseria meningitidis and a Lipopolysaccharide-Deficient Mutant
  Infection and Immunity, 2007
• Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870
  Vaccine, 2007
• The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease
  Vaccine, 2005
• Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate Vaccine
  The Journal of Immunology, 2004
• Vaccine Potential of theNeisseria meningitidis2086 Lipoprotein
  Infection and Immunity, 2004
• Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries
  The Lancet, 2003
• Clonal Groupings in Serogroup XNeisseria meningitidis
  Emerging Infectious Diseases, 2002
• Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in Africa
  The Pediatric Infectious Disease Journal, 1999